Financial News

Insiders Buy the Holdings of IDNA ETF

A look at the weighted underlying holdings of the iShares Genomics Immunology and Healthcare ETF (IDNA) shows an impressive 10.8% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying » Sarepta Therapeutics Inc (SRPT), which makes up 5.71% of the iShares Genomics Immunology and Healthcare ETF (IDNA), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback